by Chad Brueck | May 20, 2025 | MDC Blog
by Scott Robitaille It’s May! The days are longer, the weather warmer, and the flowers in full bloom. While many industries embrace a seasonal slowdown, IVD manufacturers, particularly regulatory and clinical operations teams, must take a different approach....
by Chad Brueck | May 5, 2025 | MDC Blog
by Matthew Faron The field of sexually transmitted infection (STI) diagnostics is experiencing a significant shift. Advances in technology are driving testing out of centralized laboratories and into near-patient and at-home settings. Notably, the recent FDA...
by Chad Brueck | Apr 28, 2025 | MDC Blog
by Matthew Faron The ESCMID Global 2025 conference, held from April 11–15 in Vienna, Austria, brought together leading experts in clinical microbiology and infectious diseases for five days of cutting-edge science, interactive learning, and global networking. This...
by Chad Brueck | Apr 21, 2025 | MDC Blog
by Audrey Skeen The Trump administration’s FY2026 budget proposal calls for a significant reduction in funding for the National Institutes of Health, slashing its budget from approximately $47 billion in 2025 to $27 billion in 2026. While presidential budget proposals...
by Chad Brueck | Apr 17, 2025 | MDC Blog
by Sruthi Sundaram The recent federal court decision striking down the FDA’s Laboratory Developed Test (LDT) has sparked significant discussion across the diagnostic and regulatory landscape. While the ruling represents a pivotal legal shift, its practical effect may...
by Chad Brueck | Apr 11, 2025 | MDC Blog
by Scott Robitaille In late March, the Department of Health and Human Services announced a major internal restructuring. The plan includes the elimination of approximately ten thousand federal positions and the consolidation of several key agencies under a new entity...
